Double-boosted protease inhibitor antiretroviral regimens: what role?
about
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort studyEfficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric populationSaquinavir, the pioneer antiretroviral protease inhibitor.Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future.Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients.
P2860
Double-boosted protease inhibitor antiretroviral regimens: what role?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Double-boosted protease inhibitor antiretroviral regimens: what role?
@en
Double-boosted protease inhibitor antiretroviral regimens: what role?
@nl
type
label
Double-boosted protease inhibitor antiretroviral regimens: what role?
@en
Double-boosted protease inhibitor antiretroviral regimens: what role?
@nl
prefLabel
Double-boosted protease inhibitor antiretroviral regimens: what role?
@en
Double-boosted protease inhibitor antiretroviral regimens: what role?
@nl
P1433
P1476
Double-boosted protease inhibitor antiretroviral regimens: what role?
@en
P304
P356
10.2165/0003495-200868160-00001
P577
2008-01-01T00:00:00Z
P6179
1038067919